Free Trial

StockNews.com Downgrades Joint (NASDAQ:JYNT) to Hold

Joint logo with Medical background
Remove Ads

StockNews.com lowered shares of Joint (NASDAQ:JYNT - Free Report) from a buy rating to a hold rating in a research note published on Monday morning.

Joint Stock Down 0.2 %

Shares of Joint stock traded down $0.03 on Monday, hitting $12.73. 159,414 shares of the company traded hands, compared to its average volume of 51,905. Joint has a 12-month low of $9.58 and a 12-month high of $17.82. The company has a market cap of $190.75 million, a PE ratio of -11.17 and a beta of 1.61. The company has a 50-day moving average price of $11.21 and a 200 day moving average price of $11.17.

Hedge Funds Weigh In On Joint

Hedge funds have recently added to or reduced their stakes in the company. Topline Capital Management LLC bought a new stake in Joint in the fourth quarter worth approximately $3,458,000. Clayton Partners LLC raised its holdings in Joint by 36.2% during the fourth quarter. Clayton Partners LLC now owns 310,000 shares of the company's stock valued at $3,295,000 after buying an additional 82,447 shares in the last quarter. Skylands Capital LLC boosted its stake in shares of Joint by 10.9% during the 4th quarter. Skylands Capital LLC now owns 738,728 shares of the company's stock worth $7,853,000 after acquiring an additional 72,700 shares in the last quarter. Millennium Management LLC raised its stake in shares of Joint by 46.9% in the 4th quarter. Millennium Management LLC now owns 80,982 shares of the company's stock valued at $861,000 after acquiring an additional 25,863 shares in the last quarter. Finally, O Brien Greene & Co. Inc boosted its position in Joint by 20.9% during the fourth quarter. O Brien Greene & Co. Inc now owns 144,620 shares of the company's stock worth $1,537,000 after purchasing an additional 25,000 shares during the period. Institutional investors and hedge funds own 76.88% of the company's stock.

Remove Ads

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Further Reading

Should You Invest $1,000 in Joint Right Now?

Before you consider Joint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.

While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads